Pacific Pilotage Auth Canada

The Pacific Pilotage Authority (PPA) is dedicated to providing safe, reliable, and efficient marine pilotage services in the coastal waters of British Columbia, including the Fraser River. Their principal mandate encompasses a range of related services aimed at ensuring the safe navigation of vessels in these crucial waterways. In addition to pilotage services, the PPA is involved in various operational aspects, including vessel movement data, service charges, and waivers for both pleasure craft and commercial vessels. The Authority also maintains a commitment to transparency through the publication of annual reports, strategic plans, and key performance indicators. Generated from the website

Plurilock Security Inc, based in Vancouver, BC, specializes in offering advanced cybersecurity solutions and IT services to a diverse range of clients, from commercial entities to government institutions. The company stands out for its unique Critical Services division, which tackles complex IT and cybersecurity challenges, boasting swift mobilization times that set them apart in the industry. At Plurilock, a focus on delivering innovative solutions is evident in their array of products, such as the Plurilock AI Cloud SSO/CASB and AI DLP SSO/CASB/DLP platforms, designed to enhance security measures for businesses of all sizes. Additionally, their PromptGuard AI Safety and AI Complete SSO/CASB/DLP/Continuous Authentication solutions demonstrate a commitment to comprehensive cybersecurity. With an emphasis on leveraging artificial intelligence and proprietary research, Plurilock's team, comprising experts in AI, software engineering, and cybersecurity, ensures that clients receive top-notch services tailored to their individual needs. The company's dedication to providing reliable expertise makes them a trusted partner for companies seeking robust cybersecurity solutions. Generated from the website content

NervGen Pharma Corp is a biotechnology company based in Vancouver, BC, specializing in the development of novel therapies for nerve damage and neurodegenerative diseases. The company focuses on innovative research and drug development to address unmet medical needs in the field of neurology, with a commitment to improving the quality of life for patients affected by these conditions. Generated from their business information